Physician profile
Saju Abraham
NPI 1528191756
$2,471.86
in general payments reported to CMS, 2019-2025
19 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $83.98 · 2021: $300 · 2022: $581 · 2023: $178 · 2024: $55.52 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $773.21 | 2021-2025 | Botox, Ubrelvy |
| Supernus Pharmaceuticals, INC. | $622.98 | 2019 | |
| Abbott Laboratories | $282.11 | 2019-2021 | |
| Livanova USA, INC. | $129.60 | 2022 | |
| Mdd US Operations, LLC | $121.87 | 2022 | |
| Ceribell, INC. | $104.98 | 2025 | Pocket Eeg Device |
| Alexion Pharmaceuticals, INC. | $97.48 | 2023 | Soliris |
| Kyowa Kirin, INC. | $87.06 | 2022 | |
| Biogen, INC. | $51.05 | 2022-2023 | Vumerity, Tysabri |
| Microtransponder, INC. | $31.43 | 2024 | |
| Ge Healthcare | $29.54 | 2022 | |
| Ucb, INC. | $25.82 | 2019 | |
| Lilly USA, LLC | $24.09 | 2024 | Emgality |
| Pfizer INC. | $20.57 | 2025 | |
| Novo Nordisk INC | $20.38 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.40 | 2021 | |
| Medtronic Vascular, INC. | $13.17 | 2019 | |
| Neurocrine Biosciences, INC. | $11.67 | 2021 | |
| Genentech USA, INC. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saju Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.